Concepedia

Samuel F. Lockwood

SF

28

Publications

1.4K

Citations

22

H-Index

1871

Active since

Affiliations

Hawaii Biotech (United States)(Current)

Cardax (United States)

Institute of Materials and Environmental Chemistry

Norwegian University of Science and Technology

Lung Institute

Samuel F. Lockwood is an author at Hawaii Biotech (United States) specializing in medicine, pharmacology, and biochemistry.

Top concepts

Publications per year

1871–2010

28

Publications

28

Differential effects of carotenoids on lipid peroxidation due to membrane interactions: X-ray diffraction analysis

Hyesun P. McNulty, Jungsoo Byun, Samuel F. Lockwood et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 2006 · 257 citations

, , +8

Cardioprotection and myocardial salvage by a disodium disuccinate astaxanthin derivative (Cardax™)

Garrett J. Gross, Samuel F. Lockwood · Life Sciences · 2004 · 105 citations

, , +11

Improved Aqueous Solubility of Crystalline Astaxanthin (3,3′‐dihydroxy‐β, β‐carotene‐4,4′‐dione) by Captisol® (Sulfobutyl Ether β‐Cyclodextrin)

Samuel F. Lockwood, Sean O’Malley, Gerold L. Mosher · Journal of Pharmaceutical Sciences · 2003 · 91 citations

, , +5

Rofecoxib Increases Susceptibility of Human LDL and Membrane Lipids to Oxidative Damage: A Mechanism of Cardiotoxicity

Ronald P. Mason, Mary Walter, Hyesun P. McNulty et al. · Journal of Cardiovascular Pharmacology · 2006 · 81 citations

Disodium Disuccinate Astaxanthin (Cardax) Attenuates Complement Activation and Reduces Myocardial Injury following Ischemia/Reperfusion

Adam Lauver, Samuel F. Lockwood, Benedict R. Lucchesi · Journal of Pharmacology and Experimental Therapeutics · 2005 · 70 citations

Rows per page

1–5 of 28